Jan van Tornout
Nessuna posizione attualmente
Profilo
Jan M.
van Tornout served as the Chief Medical Officer at Tyme Technologies, Inc. in 2021-2022.
He obtained his graduate degree from the University of Southern California, his undergraduate degree from Facultés Universitaires Notre-Dame de la Paix, and his graduate and doctorate degrees from Katholieke Universiteit Leuven Law School.
Precedenti posizioni note di Jan van Tornout
Società | Posizione | Fine |
---|---|---|
TYME TECHNOLOGIES, INC. | Chief Tech/Sci/R&D Officer | 01/05/2022 |
Formazione di Jan van Tornout
University of Southern California | Graduate Degree |
Facultés Universitaires Notre-Dame de la Paix | Undergraduate Degree |
Katholieke Universiteit Leuven Law School | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
Tyme Technologies, Inc.
Tyme Technologies, Inc. Pharmaceuticals: MajorHealth Technology Tyme Technologies, Inc. operates as a biotechnology company, which engages in the development and commercialization of cancer therapies. It offers a clinical program named SM-88 which is a novel, oral, and monotherapy investigational agent that aims to disrupt the cancer cell's protein synthesis. The company was founded by Steve Hoffman and Michael Demurjian on November 22, 2011 and is headquartered in Bedminster, NJ. | Health Technology |
- Borsa valori
- Insiders
- Jan van Tornout